BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38407567)

  • 1. Histological assessment of cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement.
    Beuthner BE; Elkenani M; Evert K; Mustroph J; Jacob CF; Paul NB; Beißbarth T; Zeisberg EM; Schnelle M; Puls M; Hasenfuß G; Toischer K
    ESC Heart Fail; 2024 Jun; 11(3):1636-1646. PubMed ID: 38407567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Castaño A; Narotsky DL; Hamid N; Khalique OK; Morgenstern R; DeLuca A; Rubin J; Chiuzan C; Nazif T; Vahl T; George I; Kodali S; Leon MB; Hahn R; Bokhari S; Maurer MS
    Eur Heart J; 2017 Oct; 38(38):2879-2887. PubMed ID: 29019612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis.
    Cannata F; Chiarito M; Pinto G; Villaschi A; Sanz-Sánchez J; Fazzari F; Regazzoli D; Mangieri A; Bragato RM; Colombo A; Reimers B; Condorelli G; Stefanini GG
    ESC Heart Fail; 2022 Oct; 9(5):3188-3197. PubMed ID: 35770333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.
    Rosenblum H; Masri A; Narotsky DL; Goldsmith J; Hamid N; Hahn RT; Kodali S; Vahl T; Nazif T; Khalique OK; Bokhari S; Soman P; Cavalcante JL; Maurer MS; Castaño A
    Eur J Heart Fail; 2021 Feb; 23(2):250-258. PubMed ID: 32729170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: A systematic review and meta-analysis.
    Ho JS; Kor Q; Kong WK; Lim YC; Chan MY; Syn NL; Ngiam JN; Chew NW; Yeo TC; Chai P; Poh KK; Wong RC; Lin W; Sia CH
    Hellenic J Cardiol; 2022; 64():67-76. PubMed ID: 34856378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis.
    Nitsche C; Scully PR; Patel KP; Kammerlander AA; Koschutnik M; Dona C; Wollenweber T; Ahmed N; Thornton GD; Kelion AD; Sabharwal N; Newton JD; Ozkor M; Kennon S; Mullen M; Lloyd G; Fontana M; Hawkins PN; Pugliese F; Menezes LJ; Moon JC; Mascherbauer J; Treibel TA
    J Am Coll Cardiol; 2021 Jan; 77(2):128-139. PubMed ID: 33181246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation.
    Scully PR; Patel KP; Treibel TA; Thornton GD; Hughes RK; Chadalavada S; Katsoulis M; Hartman N; Fontana M; Pugliese F; Sabharwal N; Newton JD; Kelion A; Ozkor M; Kennon S; Mullen M; Lloyd G; Menezes LJ; Hawkins PN; Moon JC
    Eur Heart J; 2020 Aug; 41(29):2759-2767. PubMed ID: 32267922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome.
    Nitsche C; Aschauer S; Kammerlander AA; Schneider M; Poschner T; Duca F; Binder C; Koschutnik M; Stiftinger J; Goliasch G; Siller-Matula J; Winter MP; Anvari-Pirsch A; Andreas M; Geppert A; Beitzke D; Loewe C; Hacker M; Agis H; Kain R; Lang I; Bonderman D; Hengstenberg C; Mascherbauer J
    Eur J Heart Fail; 2020 Oct; 22(10):1852-1862. PubMed ID: 32078212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial Injury After Transaortic Versus Transapical Transcatheter Aortic Valve Replacement.
    Ribeiro HB; Dahou A; Urena M; Carrasco JL; Mohammadi S; Doyle D; Le Ven F; Allende R; Amat-Santos I; Paradis JM; DeLarochellière R; Puri R; Abdul-Jawad Altisent O; del Trigo M; Campelo-Parada F; Pibarot P; Dumont É; Rodés-Cabau J
    Ann Thorac Surg; 2015 Jun; 99(6):2001-9. PubMed ID: 25863732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-B-type natriuretic peptide is associated with clinical outcomes after transcatheter aortic valve replacement.
    Yu J; Wang W
    J Cardiothorac Surg; 2023 Oct; 18(1):286. PubMed ID: 37817246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of N-terminal pro-B-type natriuretic peptide in patients with normal left ventricular ejection fraction undergoing transcatheter aortic valve implantation.
    Seoudy H; Kuhn C; Frank J; Eden M; Rangrez AY; Lutter G; Frey N; Frank D
    Int J Cardiol; 2020 Feb; 301():195-199. PubMed ID: 31757644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death.
    Urena M; Webb JG; Eltchaninoff H; Muñoz-García AJ; Bouleti C; Tamburino C; Nombela-Franco L; Nietlispach F; Moris C; Ruel M; Dager AE; Serra V; Cheema AN; Amat-Santos IJ; de Brito FS; Lemos PA; Abizaid A; Sarmento-Leite R; Ribeiro HB; Dumont E; Barbanti M; Durand E; Alonso Briales JH; Himbert D; Vahanian A; Immè S; Garcia E; Maisano F; del Valle R; Benitez LM; García del Blanco B; Gutiérrez H; Perin MA; Siqueira D; Bernardi G; Philippon F; Rodés-Cabau J
    J Am Coll Cardiol; 2015 Feb; 65(5):437-48. PubMed ID: 25660921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transthyretin cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: experience of a single center.
    Gallone G; Bongiovanni C; Bruno F; Landra F; Andreis A; Fava A; Scudeler L; DE Filippo O; Califaretti E; Cioffi M; Pidello S; Vairo A; Raineri C; Frea S; Giorgi M; Alunni G; Casoni R; Salizzoni S; Conrotto F; D'Ascenzo F; Rinaldi M; DE Ferrari GM
    Minerva Cardiol Angiol; 2024 Feb; 72(1):87-94. PubMed ID: 37405712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of severe aortic stenosis patients combined with diabetes mellitus after transcatheter aortic valve replacement and short-term outcome.
    Su W; Tai S; Huang Y; Hu X; Zhou S; Fang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):309-318. PubMed ID: 35545323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.
    Dobner S; Pilgrim T; Hagemeyer D; Heg D; Lanz J; Reusser N; Gräni C; Afshar-Oromieh A; Rominger A; Langhammer B; Reineke D; Windecker S; Stortecky S
    J Am Heart Assoc; 2023 Aug; 12(16):e030271. PubMed ID: 37581394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of bicuspid aortic valve or tricuspid aortic valve on hemodynamics and left ventricular reverse remodeling in patients after transcatheter aortic valve replacement].
    Zhang JQ; Chi CW; Zhao WL; Meng QT; Wang LD; Liu JY; Sun FZ; Zhang SL; Liu JH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Dec; 50(12):1193-1200. PubMed ID: 36517440
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preliminary evaluation on the efficacy of emergency transcatheter aortic valve replacement: a multicenter study].
    Zhou Z; Zhang LY; Yang J; Shang XK; Li J; Pan WZ; Jiang ZM; Fang ZF; Li F; Wu YJ; Song GY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jul; 50(7):698-704. PubMed ID: 35856227
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation of N-terminal-pro-brain natriuretic peptide with postoperative outcomes of older patients undergoing transcatheter aortic valve replacement.
    Huang YC; Chang HH; Chen PL; Chu CM; Tsai JC; Wang KY
    J Chin Med Assoc; 2023 May; 86(5):479-484. PubMed ID: 36930846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periprocedural Changes of NT-proBNP Are Associated With Survival After Transcatheter Aortic Valve Implantation.
    Seoudy H; Frank J; Neu M; Güßefeld N; Klaus Y; Freitag-Wolf S; Lambers M; Lutter G; Dempfle A; Rangrez AY; Kuhn C; Frey N; Frank D
    J Am Heart Assoc; 2019 Feb; 8(3):e010876. PubMed ID: 30686097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.